Viking Therapeutics is a clinical-stage biotech company focused on developing weight-loss therapies. Read why I rate VKTX ...
Novo Nordisk today announced 2024 earnings, reporting a 26% increase in annual sales to ~$40.56bn. Read why I upgrade NVO ...
New England Journal of Medicine Publishes eNRGy Trial Evaluating Zenocutuzumab-zbco (BIZENGRI®) in NRG1+ cancer ...
The proposed rules call for “stability studies” that far exceed FDA and USP standards, and which will cost compounding ...
SUPER strength nicotine pouches being sold in the UK could put young people at risk of accidental overdose, experts have ...
With its lung-healing properties, this antioxidant could be “an absolute game-changer” for firefighters -- if the state’s Board of Pharmacy doesn’t make it prohibitively expensive.
Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced its ...
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 05, 2025(Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodi ...
The Healthy on MSN19h
Stomach Flu vs. Food Poisoning: What’s the Difference?It’s hard to tell the difference between the stomach flu and food poisoning—but medical experts say there are a few clues ...
The fireside chat will be webcasted and available under “Events & Presentations” in the Investor Relations section of the Company’s website at www.rhythmtx.com. A replay of the webcast will be ...
Medical news in brief: Sickle cell treatment, prostate cancer, patient complaints, and other stories
Sarah Benn loses suspension appeal The retired GP and climate activist Sarah Benn lost her High Court appeal against a misconduct finding and suspension by a medical practitioners’ tribunal over her ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback